TyraTech Inc develops and commercializes efficacious proprietary insecticide and parasiticide products which incorporate unique blends of natural active ingredients. TyraTech's product array addresses a diversity of pesticide market opportunities that include consumers, commercial, professional pest control, agriculture, horticulture, human and animal health, vector control and livestock and dairy markets.
TyraTech Nature's Technology enables rapid characterization of potent mixtures of plant oil pesticides (insecticides and parasiticides). Natural plant oils are known to have various degrees of pesticidal activity, but historically have not been as effective as synthetic-chemical based products, until now.
02/02/12
Trading Update01/02/12
Change of Adviser11/01/12
Trading Update07/12/11
Migration of Shares and Block Listing Review07/12/11
Replacement: Migration of Shares
11/08/11
The firm, which owns proprietary technology based on naturally-occurring substances that it uses to develop safe pesticides, is getting nearer breakeven as its revenues increase and cost control improves
24/02/10
TyraTech enjoyed a busy year, with the successful launch of the Terminix SafeShield products, and considerable progress made through the fulfilment of development milestones with both Kraft Foods and Arysta.
04/02/10
The new deal builds on an existing relationship and extends the partnership through 2013. It now also includes professional pest control and government clients.
14/07/09
The term ‘eco-tech’ often conjures up images of wind farms and other low-carbon energy-generating technologies. But eco-tech does not just apply to direct energy generation: it can stand also for technologies that ensure human beings have access to safe sources of water and food.
02/02/12
TyraTech to continue collaboration with Terminix11/01/12
TyraTech hopes talks with Terminix will strengthen its position26/10/11
TyraTech wins latest round in Molecular Securities case25/10/11
TyraTech hires US-based consultancy to seek partners for head lice product19/10/11
TyraTech appoints David Paton as head of European operations
26/09/2011
29/06/2010
26/05/2009
TyraTech, Inc. was established in 2004 to utilize its novel technology to fill the unmet and increasing global demand for effective, safe, and natural pesticide technologies for human and animal health.
TyraTech's products incorporate a unique blend of potent natural active ingredients and are available in a number of markets including consumer, commercial, professional pest control, agriculture, human and animal health, vector control and livestock markets.
TyraTech, Inc. made its Initial Public Offering in June 2007 on the AIM section of the London Stock Exchange, where it trades under the symbol TYR. Since going public, TyraTech has established partnerships with market leaders in areas such as human health as well as consumer and commercial pest control operators.
Traditional chemical products have been the primary means for control of invertebrate pests in home and industry, as well as for personal and animal health. Unfortunately, traditional chemical products are often compromised by the development of insect resistance, environmental concerns, and adverse health effects in humans and animals. TyraTech products are designed to overcome these issues by targeting nerve centers found only in invertebrates, making our products safe for People, Pets and the Environment.
TyraTech is developing products for the agricultural and horticultural markets that are designed to address the market need for products with reduced levels of synthetic chemicals, improved safety profiles, and an ability to overcome or prevent resistance.
TyraTech Natural Agricultural and Horticultural Pesticides include EPA exempt and non-exempt active ingredients in insecticides to be incorporated into final commercial insecticide products by TyraTech's partners for application to control insects such as white flies, thrips, aphids and mites. The lead products are undergoing field testing in preparation for final formulation into partner finished products.
TyraTech intends to develop all-GRAS TyraTech Natural formulation for use as additives in companion pet and production livestock feeds to prevent certain intestinal parasite infections. This development activity is an extension of the human parasite food additive project, and TyraTech will seek a marketing partner for this product.
TyraTech's commercial and institutional business provides the operators of restaurants, hospitals, schools, hotels and other commercial enterprises with insect control products that are potent, safe, and easy to use. The TyraTech Naturals™ product line is engineered to deliver powerful insect control that's safe enough for daily use in sensitive kitchen, food storage, and customer areas.
Our proprietary natural ingredients are effective against a broad spectrum of common commercial pests including drain flies, fruit flies, cockroaches, and ants. TyraTech Naturals™ compliments professional pest control services and can be applied easily without licenses or special protective equipment. When used as part of an integrated pest management approach, TyraTech Naturals™ gives commercial enterprises the unique ability to control pests in sensitive areas without the use of synthetics.
The consumer market for pesticides demands the quick knockdown and kill of insects, but with unparalleled safety. Our products are developed with TyraTech Nature's Technology which provide consumers with an unparalleled level of potency and safety. TyraTech is continuing to develop a broad range of consumer products to meet today's demand for safe and effective insecticides and pesticides.
We have developed a product for Terminix called Terminix SafeShield. Terminix SafeShield is a ready-to-use indoor insect spray made with natural active ingredients that target nerve centers found only in invertebrate pests, not humans or pets. Please click on the Terminix SafeShield button for more information on the product.
Although infections by intestinal parasites have plagued man for centuries, there are currently no prophylactic products to keep people free from these parasites for long periods of time. Treatment, rather than prevention, has been the only choice for many governments.
Despite many years of government sponsored and non-governmental supported helminth eradication programs, it is reported that more than 2 billion people around the world are infected with intestinal parasites. Current best practice guidelines from leading health organizations focus on improving public sanitation, making potable drinking water readily available to the masses and education programs that describe the problem and how to avoid it. Unfortunately, these measures are beyond the financial resources of most of the developing countries that bear the heaviest incidence of parasitic infestation.
The Public Health segment, often referred to as the Vector Control segment, addresses the global market for products used by governmental agencies, NGOs and commercial operations to control disease-carrying insects such as mosquitoes. It includes wide-area control products and specialized products such as those used by resorts and golf courses. TyraTech's Public Health products attack insects at all stages of development and can be designed to kill or merely repel insects as the mode of operation.
Because of TyraTech products' unsurpassed safety profile, and because control occurs at various developmental stages, TyraTech products are suitable for most vector control applications. They can control mosquitoes very effectively in areas where mosquitoes breed reducing the potential of adverse effects on the population and the environment. TyraTech products can be used in applications around food and food crops, and in close proximity to humans or animals. They are even be used in and around public buildings and living quarters.
TyraTech is addressing the needs of this segment worldwide through international distributors and partnerships with established companies who lead in this segment.
Helminths (intestinal parasites) play a detrimental role in children under 15 years of age and can cause malnutrition, anemia, susceptibility to infections and cognitive impairment. Current treatment programs are not able to break the cycle of re-infestation as they cannot be administered on a more frequent basis because of their potential toxicity as well as resistance issues. While these treatments eliminate the infestation, re-infestation typically occurs quickly because of the environmental conditions where the sufferers live. TyraTech believes there is a strong need for a product that is safe to administer on a daily basis that keeps people continuously free from helminths and permanently breaks the re-infection cycle..
TyraTech has established an exclusive co-development agreement with Kraft Foods to develop a functional food product that incorporates TyraTech proprietary natural products and which can be consumed on a daily basis to keep an individual free from helminths. This innovative line of food products is in active development as a collaboration between the companies.
Mr Reade was appointed on May 25, 2007. He is owner of Global Strategy Expression Limited, a consulting and advisory services business in the life sciences industry. From 2000 until his retirement in 2005, he served as executive chairman of Merial Limited, a leading animal health company and joint venture between Merck & Co. Inc. and Sanofi- Aventis. Earlier in his career he was head of global integration at Aventis, where he was in charge of merger integration, and Chief Executive Officer and member of the Global at Rhone-Poulenc Inc. He previously has been a director of Sygen International and IFAH, a global animal health association.
He is chairman of the Remuneration Committee and member of the Nominations Committee .
Mr Hills was appointed on July 09, 2010. He spent the early portion of his career with The Gillette Company and Coca Cola USA where he held senior positions in both sales and brand management. Later, he became a 50% partner and Chief Executive Officer of Weatherly Consumer Products Inc. (Jobe's), a company which developed, branded and marketed specialty fertilizers in North America and Europe. Following the sale of that business in 1996, he and a partner started Gulfstream Home & Garden, Inc., a company which is specialised in the branding of specialist insecticide products for home and garden use which they sold in 2005, following nearly ten years of rapid growth.
Mr. Riley was appointed on May 25, 2007. After qualifying as a Chartered Accountant, he joined the Bowater Organization, where he had responsibility for the finance function at several operations. From there he moved to FMC Corporation, the U.S. conglomerate where he had finance and general management responsibilities for a specialty chemical operation, and also oversaw the head office finance function for all UK operations. He joined Proteus International Plc in 1995 as Finance Director and was closely involved in the merger with Therapeutic Antibodies Inc. in 1999, which became Protherics Plc where he was Finance Director until 2007.
He is chairman of the Audit Committee and member of the Nominations Committee.
Mr Regan was appointed on September 15, 2009. He has been employed as a senior managing director for Laurus Capital Management LLC for over 8 years. Mr. Regan also serves the same role for Valens Capital Management, LLC since its establishment in 2007. Prior to joining Laurus in 2001, Mr. Regan was an associate at Tower Hill Capital Group, an investment banking boutique and venture capital firm for two years. Prior to this, Mr. Regan spent four years as a financial analyst at Geller & Company, afinancial services accounting firm primarily providing CFO functions to private companies and financial planning for high net worth individuals. While at Geller, Mr. Regan completed and received his CPA certification (which he no longer maintains) and was involved in private placement financing, management consulting and general corporate finance functions. Mr. Regan received his B.S. in Business and Economics from Lehigh University in 1994 and his M.B.A. from Fordham University in 2000.
Nominated Adviser, Corporate Broker
Brewin Dolphin
34 Lisbon Street,
Leeds,
LS1 4LX
+44 (0)113 241 0138
Financial PR Advisers
Buchanan Communications
107 Cheapside,
London, EC2V 6DN, UK
+44 (0) 20 7466 5000
Auditors
Grant Thornton
200 S. Orange Avenue,
Suite 2050,
Orlando, FL 32801,
USA
Registrars
Computershare Investor Services (Channel Islands) Limited
Queensway House,
Hilgrove Street,
St. Helier,
Jersey, JE1 1ES
TyraTech, Inc.
1901 South Harbor City Blvd.
Suite 400
Melbourne, FL 32901
Tel: 866.951.2847
webinfo@tyratech.com
For investor relations, please contact:
Brewin Dolphin
Corporate Advisory & Broking
12 Smithfield Street
London EC1A 9BD
Tel: +44 (0) 0845 213 1300
iain.marlow@brewin.co.uk
As at 01 February 2011, there were 51,837,468 shares in issue (of which 51,823,723 are entitled to vote excluding 13,745 of treasury Stock)
As at 01 February 2011, shareholders holding more than 3% of the share capital of TyraTech Inc were:
| Sustainable Asset Man | 6,667,744 | 12.9% |
| Vanderbilt University | 5,086,799 | 9.8% |
| Standard Life Inv Ltd | 4,905,581 | 9.5% |
| Fiske nominees | 4,453,889 | 8.6% |
| Alan Reade | 4,071,808 | 7.9% |
| Ora Capital | 3,810,178 | 7.4% |
| Legal & General | 1,961,872 | 3.8% |
In the terms of AIM Rules published February 2010 and insofar as it is aware, at 01 February 2011, 59.72% of the Company's AIM securities were not in public hands.
Click here for further information
Updated 20th April 2011
Copyright © Proactiveinvestors.co.uk, 2010. All Rights Reserved Design & Development: Tehnicom Computers
